Posters
« Back
NPRA signaling in the Tumor/Stroma Microenvironment Influences the Growth of Stem-like Cancer Cells
EP25407
Poster Title: NPRA signaling in the Tumor/Stroma Microenvironment Influences the Growth of Stem-like Cancer Cells
Submitted on 24 Feb 2017
Author(s): Ryan Green1 Mark C Howell1 Dr. Rajesh Nair1, PhD Shruti Padhee1, Ph.D Scott J Antonia, MD2 PhD Dr. Eva Samal1 Jit Banerjee1 Shyam Mohapatra1 Subhra Mohapatra1
Affiliations: 1University of South Florida 2Moffitt Cancer Center
This poster was presented at USF Health Research Day
Poster Views: 631
View poster »


Poster Information
Abstract: With growing evidence supporting the role of cancer stem cells (CSCs) in tumorigenesis, tumor heterogeneity, resistance to chemotherapeutic and radiation therapies, and the metastatic phenotype, the development of specific therapies that target CSCs holds promise for improving survival and quality of life for cancer patients, especially those with metastatic disease. Thus, there is an urgent need for the development of novel therapeutic agents that target lung CSCs, specifically agents that target CSC self-renewal, regeneration or differentiation processes. The natriuretic peptide receptor A (NPRA) signaling pathway is involved in tumor progression and may also be involved in CSC development. We reasoned that alterations to NPRA expression and signaling might lead to inhibition of CSC proliferation. To investigate this, we report the development of a tumor/stroma co-culture model to study and further define the role that NPRA plays in CSC development and drug resistance.
Summary: Therapies that target cancer stem cells hold promise for improving survival of cancer patients.There is an urgent need for the development of novel therapeutic agents that target lung CSCs. The natriuretic peptide receptor A signaling pathway is involved in tumor progression and CSC development. Changes to NPRA expression and signaling might lead to inhibition of CSC proliferation. We report a tumor/stroma co-culture model to study the role that NPRA plays in CSC development and drug resistanceReferences: 1Report abuse »
Creative Commons

Related Posters


Streamlining Biologics Development with the Expi Expression Systems
Chao Yan Liu, Jian Liu, Wanhua Yan, Kyle Williston, Kenneth Thompson, Maya Yovcheva, Sara Barnes, Mark Bundy, Melissa Cross, Katy Irvin, Joaquín Canay, Mary Reynolds, Natasha Lucki, Henry Chiou, Andrew Campbell, Jonathan Zmuda

ExpiSf™ Expression system: A Chemically Defined Baculovirus-Based System for Enhanced Protein and Virus Production in Sf9 Cells
Kenneth Thompson, Maya Yovcheva, Sara Barnes, Melissa Cross, Katy Irvin, Natasha Lucki, Henry Chiou, and Jonathan Zmuda

Optimized Expression of Membrane Proteins in the Expi293 and ExpiCHO Expression Systems: New Tools for Difficult to Express Proteins
Chao Yan Liu1, Jian Liu1, Wanhua Yan1, Sam Stepnowski1 ,Kyle Williston1, Katy Irvin1, Chetana Revankar2, Natasha Lucki2, Henry Chiou2, Jonathan Zmuda1. Thermo Fisher Scientific, 1Frederick, MD, U.S.A, 2Carlsbad, CA, U.S.A

Primary Human Hepatocytes 3D in vitro Culture Model for Studying Hepatic Function
Sujoy Lahiri, Julia Tritapoe, Kate Comstock, Michael F. Millett, Mark Kennedy, Theresa V. Nguyen, Deborah K. Tieberg, David T. Kuninger

Delivery of RNP complexes for CRISPRi (dCas9) silencing in vitro and in vivo using crystalline ultrasmall particles (CUSP)
GM Unger*, VL Korman, BT Kren, DL Tobolt